← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vion Pharmaceuticals, Inc.
New Haven, CT
$1,557,382
Total funding
8
Grants
Funding mix
By agency
NIH$1,557,382 · 8
By mechanism
R44$750,000 · 1
R43$666,050 · 6
N01$141,332 · 1
Investigators at Vion Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
BACTERIAL GENE DELIVERY VECTORS FOR CANCER THERAPY$375,000
R44 · FY2000 · CA
BACTERIAL GENE DELIVERY VECTORS FOR CANCER THERAPY$375,000
R44 · FY2001 · CA
Determination of Triapine Antiviral Activity$166,050
R43 · FY2003 · AI
PRELIMINARY VALIATION OF NON-INVASIVE TUMOR IMAGING BY T$141,332
N01 · FY2000 · CO
SALMONELLA WITH INDUCIBLE ANTICANCER GENES$100,000
R43 · FY2000 · CA
Genetic Improvements of Tumor-Targeted Salmonella$100,000
R43 · FY2002 · CA
POTENTIATING THE ANTI-TUMOR ACTIVITY OF SALMONELLA$100,000
R43 · FY2002 · CA
Identification of tumoricidal compounds in Salmonella$100,000
R43 · FY2003 · CA
Akylating agent Water-soluble Sulfonyl Hydrazine Prodrug$100,000
R43 · FY2001 · CA